Videos | Page 5

Sara Anvari, MD, discusses the function of histamine in the immune response and treatment with antihistamines.
Leonard Bielory, MD, reviews challenging cases of ocular allergy and discusses treatment options.
Luz Fonacier, MD, talks about the diagnosis and management of atopic dermatitis.
Jonathan G. Marquess, PharmD, CDE, explains that employers can save a great deal on health care costs by helping their employees with diabetes effectively manage their condition.
Jeff Fudin, PharmD, FCCP, argues that the way to make hydrocodone combination products safer for patients is to provide more education for those who prescribe the medications and pharmacists who dispense them.
Mary Lynn McPherson, PharmD, explains why hydrocodone combination products should no longer be categorized as Schedule III drugs.
Jeff Fudin, PharmD, FCCP, argues that categorizing hydrocodone combination products as Schedule II could lead to increased prescription of codeine, a much “sloppier” drug that could create problems for patients.
Mary Lynn McPherson, PharmD, argues that rescheduling hydrocodone combination products will lead to more responsible prescribing of the drugs and monitoring of their use.
Jeff Fudin, PharmD, FCCP, discusses the effect of rescheduling hydrocodone combination products as CII in New York State on prescription of other opioids, including oxycodone.
Mary Lynn McPherson, PharmD, explains how rescheduling hydrocodone combination products as Schedule II drugs will help reduce levels of abuse.
Latest Issues